尼古丁干预与沟通赋能减害(NICER):针对吸烟优先人群的随机对照试验研究方案
本研究为多中心、开放标签、平行组随机对照试验,计划纳入1230名吸烟成人,按1:1随机分为极低尼古丁香烟(VLNC)加信息传递组与VLNC单独组,评估信息传递对每日吸烟支数等结局的影响。研究对象重点关注低社会经济地位(SES)和严重心理困扰(SPD)人群。
要点
- 多中心开放标签平行组随机对照试验,计划纳入1230名吸烟成人,每组410人。
- 干预为VLNC加信息传递(包装插页和数字广告)对比VLNC单独使用。
- 主要结局为第4周每日吸烟支数,次要结局包括其他烟草使用、尼古丁依赖等。
核心结论
- 该试验将首次在优先人群中评估伴随VLNC使用的信息传递活动的效果,结果将为FDA监管策略和公共卫生信息提供依据。
研究设计与样本
- 多中心、开放标签、平行组随机对照试验,计划纳入1230名吸烟成人,按1:1随机分为VLNC加信息传递组和VLNC单独组。
- 纳入人群包括严重心理困扰(SPD)、低社会经济地位(SES)及两者均无者,每组410人。
- 基线期1周,干预期4周,参与者通过短信完成每日日志并每周访问收集数据。
主要发现
- 主要结局为第4周每日吸烟支数。
- 次要结局包括其他烟草产品使用、尼古丁依赖、放弃吸烟和戒烟意向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Smoking is a leading cause of preventable death, disproportionately affecting people with low socioeconomic status (SES) and serious psychological distress (SPD). The U.S. Food and Drug Administration (FDA) has proposed reducing nicotine levels in cigarettes and other combusted tobacco products to minimally addictive levels, a policy with significant public health potential. However, misperceptions about very low nicotine cigarettes (VLNCs), such as beliefs that they are less harmful or ineffective for quitting, may reduce policy effectiveness. While previous randomized controlled trials (RCTs) have examined the effects of using VLNCs, none have incorporated messaging to address misperceptions. This study evaluates the impact of a messaging campaign on smoking behaviors, risk perceptions, and quit intentions among people who smoke, focusing on individuals with low SES, SPD, and neither. The primary objective is to assess whether exposure to VLNC-related messages reduces the number of cigarettes smoked per day compared to VLNC use alone. Secondary objectives include examining effects on other tobacco product use, nicotine dependence, forgoing cigarettes, perceived risks, and quit intentions. METHODS: This multi-site, open-label, parallel-arm RCT will enroll 1230 adults who smoke (n = 410 per group: with SPD, low SES, neither category). After a 1-week baseline period, participants will be randomized (1:1) to receive either (1) VLNCs with messaging or (2) VLNCs only (control). Messaging will include pack inserts and digital ads shown during weekly visits to address misperceptions and encourage quitting. Participants will complete daily logs via text messages and attend weekly visits over 4 weeks for data collection, including self-reported smoking behavior, expired carbon monoxide (CO) samples, and questionnaire assessments. The primary outcome is the number of cigarettes smoked per day in the final study week (week 4). Secondary outcomes include the use of other tobacco products, nicotine dependence, forgoing cigarettes, and quit intentions. DISCUSSION: This trial will be the first to examine the effects of a messaging campaign accompanying VLNC use among priority populations. Results will inform FDA regulatory strategies and public health messaging to support nicotine reduction policy implementation. TRIAL REGISTRATION: ClinicalTrials.gov NCT06787937. Registered on 22 January 2025.
引用
- Pei D, Juris A, Nkansah P, et al. Nicotine Intervention and Communication for Empowering Reduction (NICER): study protocol for a randomized controlled trial among priority populations of people who smoke. Trials. 2025. PMID: 41250122. doi:10.1186/s13063-025-09216-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。